Neuroendocrine Prostate Cancer Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

Neuroendocrine Prostate Cancer Market is segmented By Treatment (Chemotherapy, Hormonal Therapy), By Stage of Disease (Localized, Metastatic), By Therapeutics (Immunotherapy, Targeted Therapy), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD Million) for the above-mentioned segments.

Neuroendocrine Prostate Cancer Market is segmented By Treatment (Chemotherapy, Hormonal Therapy), By Stage of Disease (Localized, Metastatic), By Ther....

Neuroendocrine Prostate Cancer Market Size

Market Size in USD

CAGR7.1%

Study Period	2024 - 2031
Base Year of Estimation	2023
CAGR	7.1%
Market Concentration	Medium
Major Players	Amgen, BioXcel Therapeutics, Oric Pharmaceuticals, Xencor, Astellas Pharma/Medivation

*Disclaimer: Major players are listed in no particular order.

*Source: Coherent Market Insights

Want to purchase customized report?
please let us know !

Neuroendocrine Prostate Cancer Market Analysis

The neuroendocrine prostate cancer market is estimated to be valued at USD 964.1 Mn in 2024 and is expected to reach USD 1,560.5 Mn by 2031, growing at a compound annual growth rate (CAGR) of 7.1% from 2024 to 2031. The increasing prevalence of prostate cancer globally is expected to drive the demand for effective treatment options.

Neuroendocrine Prostate Cancer Market Report Snapshots

Buy Now